Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-193527
Filing Date
2015-05-19
Accepted
2015-05-19 16:56:18
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d922847d10q.htm 10-Q 257374
2 EX-31.1 d922847dex311.htm EX-31.1 9054
3 EX-31.2 d922847dex312.htm EX-31.2 9175
4 EX-32.1 d922847dex321.htm EX-32.1 4587
  Complete submission text file 0001193125-15-193527.txt   3224261

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rswn-20150331.xml EX-101.INS 364909
6 XBRL TAXONOMY EXTENSION SCHEMA rswn-20150331.xsd EX-101.SCH 39145
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rswn-20150331_cal.xml EX-101.CAL 48912
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rswn-20150331_def.xml EX-101.DEF 149126
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rswn-20150331_lab.xml EX-101.LAB 303414
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rswn-20150331_pre.xml EX-101.PRE 230662
Mailing Address 16200 WCR 18E LOVELAND CO 80537
Business Address 16200 WCR 18E LOVELAND CO 80537 (970) 635-0346
Rosewind CORP (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: CO | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-53121 | Film No.: 15877138
SIC: 2834 Pharmaceutical Preparations